Wire · opportunities
Medibyt Receives FDA 510(k) Clearance for CPETWise, Advancing ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 1 September 2026 · Fusion42 review
Medibyt received FDA 510(k) clearance for CPETWise, enabling U.S. commercialization of its AI-driven cardiopulmonary exercise test analysis software and accelerating clinical adoption and strategic partnerships.
This Wire brief sits within Fusion42's coverage of Digital Health, and 5 sources have reported it between 1 Sep 2026 and 4 Sep 2026.
◆ ◆ The Wire takeaway
You now have a new route to enter the U.S. market with AI-powered cardiopulmonary diagnostics as Medibyt's clearance cuts the regulatory barrier. Move quickly to build partnerships with U.S. clinical labs where faster, standardised CPET reporting is a growing demand.
◆ Coverage
5 sources · first reported 1 Sep 2026 · latest 4 Sep 2026
◆ Related on Wire
◆ Topics